These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25302254)

  • 61. Pityriasis Rosea: A Comprehensive Classification.
    Drago F; Ciccarese G; Rebora A; Broccolo F; Parodi A
    Dermatology; 2016; 232(4):431-7. PubMed ID: 27096928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Atypical pityriasis rosea and Hodgkin's disease.
    Garcia-F-Villalta MJ; Hernández-Nuñez A; Córdoba S; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):81-2. PubMed ID: 14678538
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection.
    Mubki TF; Bin Dayel SA; Kadry R
    Pediatr Dermatol; 2011; 28(3):341-2. PubMed ID: 20403114
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Idiopathic eruptive macular pigmentation following pityriasis rosea. Presentation of two cases (author's transl)].
    Dupré A; Christol B; Albarel N; Rumeau H
    Ann Dermatol Venereol; 1980 May; 107(5):413-7. PubMed ID: 7224525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.
    Drago F; Broccolo F; Rebora A
    J Am Acad Dermatol; 2009 Aug; 61(2):303-18. PubMed ID: 19615540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunological studies of pityriasis rosea (Gibert).
    Takaki Y; Koshiyama Y; Watanabe S
    J Dermatol; 1977 Feb; 4(1):37-40. PubMed ID: 16688920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pityriasis rosea-like adverse reaction to atenolol.
    Güleç Aİ; Albayrak H; Kayapinar O; Albayrak S
    Hum Exp Toxicol; 2016 Mar; 35(3):229-31. PubMed ID: 25791321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Histopathology of pityriasis rosea Gibert. Qualitative and quantitative light-microscopic study of 62 biopsies of 40 patients.
    Panizzon R; Bloch PH
    Dermatologica; 1982; 165(6):551-8. PubMed ID: 7169130
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isotretinoin dermatitis simulating acute pityriasis rosea.
    Helfman RJ; Brickman M; Fahey J
    Cutis; 1984 Mar; 33(3):297-300. PubMed ID: 6233097
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution.
    Ayanlowo O; Akinkugbe A; Olumide Y
    Nig Q J Hosp Med; 2010; 20(1):29-31. PubMed ID: 20450028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Skin rash mimicking pityriasis rosea Gibert secondary to pristinamycin therapy].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2014 Apr; 141(4):325-6. PubMed ID: 24703654
    [No Abstract]   [Full Text] [Related]  

  • 73. Palmar herald patch in pityriasis rosea.
    Polat M; Yildirim Y; Makara A
    Australas J Dermatol; 2012 Aug; 53(3):e64-5. PubMed ID: 22881477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dermoscopy in General Dermatology: A Practical Overview.
    Errichetti E; Stinco G
    Dermatol Ther (Heidelb); 2016 Dec; 6(4):471-507. PubMed ID: 27613297
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Vesicular pityriasis rosea].
    Strauss T; Kuhn A; Steigleder GK
    Hautarzt; 1988 Aug; 39(8):524-6. PubMed ID: 3220767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).
    Cho AY; Kim DH; Im M; Lee Y; Seo YJ; Lee JH
    Ann Dermatol; 2011 Dec; 23(Suppl 3):S360-3. PubMed ID: 22346278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytolytic degeneration of keratinocytes adjacent to Langerhans cells in pityriasis rosea (Gibert).
    Takaki Y; Miyazaki H
    Acta Derm Venereol; 1976; 56(2):99-103. PubMed ID: 58531
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atypical pityriasis rosea.
    Imamura S; Ozaki M; Oguchi M; Okamoto H; Horiguchi Y
    Dermatologica; 1985; 171(6):474-7. PubMed ID: 4092804
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tongue and cheek: oral lesions in pityriasis rosea.
    Vidimos AT; Camisa C
    Cutis; 1992 Oct; 50(4):276-80. PubMed ID: 1424793
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea.
    Lim SH; Kim SM; Oh BH; Ko JH; Lee YW; Choe YB; Ahn KJ
    Ann Dermatol; 2009 Aug; 21(3):230-6. PubMed ID: 20523795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.